Veerhealth Care Limited has announced a significant new order that is expected to boost its growth and turnover. The company has secured a contract worth Rs 0.81 crore from one of India's leading pharmacy chains for the manufacturing and supply of hair care and oral care products.

Order Details

The order, which is domestic in nature, comes from a prominent pharmacy chain that operates over 5,000 retail outlets across India, representing the largest retail pharmacy network in the country. Veerhealth Care is required to execute this order within a tight timeframe of 20 days, highlighting the company's production capabilities and the client's trust in their ability to deliver.

Product Range and Market Expansion

This new contract encompasses the manufacturing and supply of hair care and oral care products, showcasing Veerhealth Care's diverse product portfolio in the personal care segment. The order from such a large retail network could potentially lead to increased visibility and market penetration for Veerhealth Care's products.

Financial Impact and Growth Prospects

The company expects this order to contribute to its growth and turnover. While the exact impact on financials has not been disclosed, securing a contract with a major player in the retail pharmacy sector could open doors for future collaborations and expansion opportunities.

Corporate Governance and Transparency

In compliance with SEBI regulations, Veerhealth Care has provided additional details about the order:

• The order is from a domestic entity.
• It does not involve any related party transactions.
• There is no interest from the promoter or promoter group in the entity that awarded the contract.

Management Commentary

Bhavin S. Shah, Managing Director of Veerhealth Care Limited, signed off on the regulatory filing, indicating the company's commitment to transparency and adherence to disclosure norms.

This new order represents a positive development for Veerhealth Care Limited, potentially strengthening its position in the personal care products market and setting the stage for future growth in the competitive retail pharmacy sector.

Veerhealth Care Limited , a prominent player in the healthcare sector, has announced a significant boost to its export business with a new order from a US-based customer. The company has secured an order worth Rs 0.45 crore for its oral care products, marking a notable step in expanding its presence in the US market.

Order Details

The order, which involves the manufacture and supply of oral care products, specifically includes:

• 2 x 40 FT FCL (Full Container Load) containers
• Drug OTC (Over-The-Counter) range products
• Execution timeline of 30 days

Strategic Importance

This new order is expected to play a major role in Veerhealth Care's export business in the US market. The company views this as an opportunity to strengthen its foothold in the international arena, particularly in the competitive US healthcare sector.

Customer Confidentiality

Due to the terms of a Non-Disclosure Agreement (NDA), the identity of the US customer remains undisclosed. This practice is common in international business dealings, especially when dealing with sensitive market information or proprietary product details.

Corporate Governance

In compliance with SEBI regulations, Veerhealth Care has provided additional details about the order:

• The order was awarded by an international entity
• It does not involve any related party transactions
• There is no interest from the promoter or promoter group companies in the entity that awarded the order

Management's Perspective

Bhavin S. Shah, Managing Director of Veerhealth Care Limited, signed off on the regulatory filing, underlining the company's commitment to transparency and adherence to disclosure norms.

This development underscores Veerhealth Care's efforts to expand its international presence and boost its export business. The successful execution of this order within the stipulated timeframe could pave the way for more opportunities in the US market, potentially leading to sustained growth in the company's export segment.